Manufacturing consultancy up 150% as life sciences prepare for a digital future

30 Jan 2019

Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.

Zenith Technologies has seen a 150% rise in demand for its consultancy arm services. The company's consultancy has seen an increasing appetite for digitised manufacturing and using data to improve GMP manufacturing over the past 12 months.

Manufacturing consultancy up 150% as life sciences prepare for a digital future

The growth of the service in 2018 was driven by a need to aid customers in collecting, contextualising and finding insights in their stored data. These insights can then be used to make informed decisions on production processes and the supply chain.

Jaqueline Hora, Global Digital and Data Analytics Lead at Zenith Technologies said: “The life science industry has seen a remarkable trend towards innovation utilising data and technology effectively. Digital strategies, as well as manufacturing execution systems (MES) and automation, are in great demand as a result.

“For customers implementing these digital strategies, project decision support as well as process, technology and project execution knowledge, are essential to ensure success.

“Our Consultancy team supports customers that are considering new technology projects and assists in developing strategies, governance and standards to provide a framework for success.

“Whether it be justifying ROI, validating a customer’s strategy, process and methodology implementation expertise or help with technology selection, Zenith has been there to support its customer base.

“Zenith’s intimate understanding of manufacturing systems, extensive process knowledge and significant experience serving the life science sector has ensured that our customers have the insight needed to make the best decision.”

The increase is in part a direct result of the emergence of Industry 4.0 with data integrity, data analytics, the internet of things, and cloud strategies becoming a reality throughout the life science industry.

The team’s growth is projected to continue into 2019 as the life science industry increases its focus on digitisation and using data to improve GMP manufacturing practices.

In a recent survey of the industry, Zenith found nearly 60% of participants believe that Industry 4.0 will drive the most change in life science over the next 5 years, with 75% of those aiming to invest in people to take advantage of emerging technologies.

Read More

Related news

Eisai collaborates with University of Dundee on cancer drug discovery

Eisai collaborates with University of Dundee on cancer drug discovery

10 Jul 2019

It is hoped that research into PROTACs will lead to new drug discoveries for proteins present in cancer, which are difficult to treat with conventional small molecule inhibitors.

Read more 
Onyx Scientific makes strategic investment in commercial API licence

Onyx Scientific makes strategic investment in commercial API licence

10 Jul 2019

Investment fills the growing gap in the market for manufacturers that have the niche capabilities to deliver small-scale commercial API projects.

Read more 
I Holland to share the science behind tool maintenance

I Holland to share the science behind tool maintenance

9 Jul 2019

Proper maintenance - rather than replacement - of compression tooling will improve profitability.

Read more 
Catalent extends global commercial spray drying capabilities in Europe

Catalent extends global commercial spray drying capabilities in Europe

9 Jul 2019

Company's customers to have immediate access to Niro PSD2 and PSD4 spray driers, which are supported by dedicated clean area facilities for both solvent and aqueous processing of potent or non-potent drug formulations.

Read more 
Operations commence at Wasdell Group’s EU headquarters

Operations commence at Wasdell Group’s EU headquarters

8 Jul 2019

The new facility houses 11 bespoke production suites and temperature controlled high-way warehouses increases Wasdell’s capacity in clinical and commercial packaging, distribution & logistics and QP services.

Read more 
Porvair Sciences launches first Drosophila ChIP kits

Porvair Sciences launches first Drosophila ChIP kits

4 Jul 2019

Offers a single optimised Chromatrap kit with unique buffers and components for Drosophila chromatin extraction and ChIP.

Read more 
Boehringer Ingelheim expands NASH R&D pipeline with new first-in-class compound

Boehringer Ingelheim expands NASH R&D pipeline with new first-in-class compound

3 Jul 2019

Yuhan Corporation to receive up to USD 870 million in upfront and success-based development and commercialization milestones, excluding royalties.

Read more 
Fresh data on protein interactions in Alzheimer’s disease

Fresh data on protein interactions in Alzheimer’s disease

2 Jul 2019

Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.

Read more 
Fujifilm Irvine Scientific to open new cell culture media manufacturing site in Europe

Fujifilm Irvine Scientific to open new cell culture media manufacturing site in Europe

2 Jul 2019

The space will support cGMP manufacturing of animal component-free, dry powder media, liquid media, and downstream bioprocessing liquids.

Read more 
Novartis bolsters ophthalmic portfolio with acquisition of Xiidra

Novartis bolsters ophthalmic portfolio with acquisition of Xiidra

1 Jul 2019

Xiidra 5% is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.

Read more